Annexes to the interim recommendations for use of the ChAdOx1-S [recombinant] vaccine against COVID-19 (AstraZeneca COVID-19 vaccine AZD1222, SII Covishield, SK Bioscience): grading of evidence - evidence to recommendations tables, first issued 10 February 2021, updated 21 April 2021